Singapore manufacturing

LONDON: AstraZeneca has unveiled plans to construct a state-of-the-art manufacturing facility in Singapore, dedicated to the production of antibody drug conjugates (ADCs). This $1.5 billion venture marks the company’s first foray into manufacturing within Singapore and represents a significant step…